Bipolar Disorder Medications - Global and China Top Players Market Share and Ranking 2023
Bipolar Disorder Medications - Global and China Top Players Market Share and Ranking 2023
The Bipolar Disorder Medications Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to latest Research, the global market for Bipolar Disorder Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Bipolar Disorder Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Bipolar Disorder Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient's mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
This report studies and analyses global Bipolar Disorder Medications status and future trends, helps the client to determine the Bipolar Disorder Medications market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Bipolar Disorder Medications, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Bipolar Disorder Medications market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Bipolar Disorder Medications sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Bipolar Disorder Medications sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Bipolar Disorder Medications key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Bipolar Disorder Medications key producing regions, capacity, production, and year over year growth
(6) Bipolar Disorder Medications industry chains, upstream, midstream and downstream
Market segment by players, this report covers
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
Market segment by Type, covers
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Bipolar Disorder Medications product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Bipolar Disorder Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Bipolar Disorder Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Bipolar Disorder Medications, percent & CAGR, 2018-2029
Chapter 5: Bipolar Disorder Medications industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Bipolar Disorder Medications Definition
1.2 Global Bipolar Disorder Medications Market Size and Forecast
1.2.1 By Consumption Value, Global Bipolar Disorder Medications Market Size，2018-2029
1.2.2 By Sales Quantity, Global Bipolar Disorder Medications Market Size，2018-2029
1.2.3 Global Bipolar Disorder Medications Average Selling Price (ASP)，2018-2029
1.3 China Bipolar Disorder Medications Market Size and Forecast
1.3.1 By Consumption Value, China Bipolar Disorder Medications Market Size，2018-2029
1.3.2 By Sales Quantity, China Bipolar Disorder Medications Market Size，2018-2029
1.3.3 China Bipolar Disorder Medications Average Selling Price (ASP)， 2018-2029
1.4 Share of China Bipolar Disorder Medications Market with Respect to the Global Market
1.4.1 By Consumption Value, China Bipolar Disorder Medications Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Bipolar Disorder Medications Market Share in Global, 2018-2029
1.4.3 Bipolar Disorder Medications Market Size: China VS Global, 2018-2029
1.5 Bipolar Disorder Medications Market Dynamics
1.5.1 Bipolar Disorder Medications Market Drivers
1.5.2 Bipolar Disorder Medications Market Restraints
1.5.3 Bipolar Disorder Medications Industry Trends
1.5.4 Bipolar Disorder Medications Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Bipolar Disorder Medications, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Bipolar Disorder Medications, Global Market Share by Company, 2018-2023
2.3 Bipolar Disorder Medications Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Bipolar Disorder Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Bipolar Disorder Medications Concentration Ratio
2.6 Global Bipolar Disorder Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Bipolar Disorder Medications Manufacturers Product Type
2.8 Head Office and Bipolar Disorder Medications Production Site of Key Manufacturer
2.9 Bipolar Disorder Medications Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Bipolar Disorder Medications, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Bipolar Disorder Medications, China Market Share by Company, 2018-2023
3.3 China Bipolar Disorder Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Bipolar Disorder Medications Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Bipolar Disorder Medications Capacity by Region
4.3 Global Bipolar Disorder Medications Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Bipolar Disorder Medications Production by Region, 2018-2029
4.5 Global Bipolar Disorder Medications Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Bipolar Disorder Medications Industry Chain
5.2 Bipolar Disorder Medications Upstream Analysis
5.2.1 Bipolar Disorder Medications Core Raw Materials
5.2.2 Main Manufacturers of Bipolar Disorder Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Bipolar Disorder Medications Production Mode
5.6 Bipolar Disorder Medications Procurement Model
5.7 Bipolar Disorder Medications Industry Sales Model and Sales Channels
5.7.1 Bipolar Disorder Medications Sales Model
5.7.2 Bipolar Disorder Medications Typical Distributors
6 Sights by Type
6.1 Bipolar Disorder Medications Classification
6.1.1 Mood Stabilizers
6.1.2 Anticonvulsants
6.1.3 Antipsychotic Drugs
6.1.4 Antidepressant Drugs
6.1.5 Anti-Anxiety Drugs
6.2 By Type, Global Bipolar Disorder Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Bipolar Disorder Medications Consumption Value, 2018-2029
6.4 By Type, Global Bipolar Disorder Medications Sales Quantity, 2018-2029
6.5 By Type, Global Bipolar Disorder Medications Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Bipolar Disorder Medications Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Bipolar Disorder Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Bipolar Disorder Medications Consumption Value, 2018-2029
7.4 By Application, Global Bipolar Disorder Medications Sales Quantity, 2018-2029
7.5 By Application, Global Bipolar Disorder Medications Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Bipolar Disorder Medications Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Bipolar Disorder Medications Consumption Value, 2018-2029
8.3 By Region, Global Bipolar Disorder Medications Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Bipolar Disorder Medications & Forecasts, 2018-2029
8.4.2 By Country, North America Bipolar Disorder Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Bipolar Disorder Medications Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Bipolar Disorder Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Bipolar Disorder Medications Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Bipolar Disorder Medications Market Size Market Share
8.7 South America
8.7.1 South America Bipolar Disorder Medications Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Bipolar Disorder Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Bipolar Disorder Medications Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Bipolar Disorder Medications Consumption Value, 2018-2029
9.3 By Country, Global Bipolar Disorder Medications Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Bipolar Disorder Medications Market Size, 2018-2029
9.4.2 By Type, U.S. Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Bipolar Disorder Medications Market Size, 2018-2029
9.5.2 By Type, Europe Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Bipolar Disorder Medications Market Size, 2018-2029
9.6.2 By Type, China Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Bipolar Disorder Medications Market Size, 2018-2029
9.7.2 By Type, Japan Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Bipolar Disorder Medications Market Size, 2018-2029
9.8.2 By Type, South Korea Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Bipolar Disorder Medications Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Bipolar Disorder Medications Market Size, 2018-2029
9.10.2 By Type, India Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Bipolar Disorder Medications Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbbVie Inc.
10.1.1 AbbVie Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 AbbVie Inc. Bipolar Disorder Medications Models, Specifications, and Application
10.1.3 AbbVie Inc. Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbbVie Inc. Company Profile and Main Business
10.1.5 AbbVie Inc. Recent Developments
10.2 Glaxo SmithKline (GSK)
10.2.1 Glaxo SmithKline (GSK) Company Information, Head Office, Market Area, and Industry Position
10.2.2 Glaxo SmithKline (GSK) Bipolar Disorder Medications Models, Specifications, and Application
10.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Glaxo SmithKline (GSK) Company Profile and Main Business
10.2.5 Glaxo SmithKline (GSK) Recent Developments
10.3 Eli Lily and Company
10.3.1 Eli Lily and Company Company Information, Head Office, Market Area, and Industry Position
10.3.2 Eli Lily and Company Bipolar Disorder Medications Models, Specifications, and Application
10.3.3 Eli Lily and Company Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Eli Lily and Company Company Profile and Main Business
10.3.5 Eli Lily and Company Recent Developments
10.4 Janssen Pharmaceuticals
10.4.1 Janssen Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Janssen Pharmaceuticals Bipolar Disorder Medications Models, Specifications, and Application
10.4.3 Janssen Pharmaceuticals Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Janssen Pharmaceuticals Company Profile and Main Business
10.4.5 Janssen Pharmaceuticals Recent Developments
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.5.2 Johnson & Johnson Bipolar Disorder Medications Models, Specifications, and Application
10.5.3 Johnson & Johnson Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Johnson & Johnson Company Profile and Main Business
10.5.5 Johnson & Johnson Recent Developments
10.6 Astellas Pharma Inc
10.6.1 Astellas Pharma Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Astellas Pharma Inc Bipolar Disorder Medications Models, Specifications, and Application
10.6.3 Astellas Pharma Inc Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Astellas Pharma Inc Company Profile and Main Business
10.6.5 Astellas Pharma Inc Recent Developments
10.7 Bristol Myers Squibb
10.7.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bristol Myers Squibb Bipolar Disorder Medications Models, Specifications, and Application
10.7.3 Bristol Myers Squibb Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bristol Myers Squibb Company Profile and Main Business
10.7.5 Bristol Myers Squibb Recent Developments
10.8 Gedeon Richter PLC.
10.8.1 Gedeon Richter PLC. Company Information, Head Office, Market Area, and Industry Position
10.8.2 Gedeon Richter PLC. Bipolar Disorder Medications Models, Specifications, and Application
10.8.3 Gedeon Richter PLC. Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Gedeon Richter PLC. Company Profile and Main Business
10.8.5 Gedeon Richter PLC. Recent Developments
10.9 H. Lundbeck A/S
10.9.1 H. Lundbeck A/S Company Information, Head Office, Market Area, and Industry Position
10.9.2 H. Lundbeck A/S Bipolar Disorder Medications Models, Specifications, and Application
10.9.3 H. Lundbeck A/S Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 H. Lundbeck A/S Company Profile and Main Business
10.9.5 H. Lundbeck A/S Recent Developments
10.10 Pfizer Inc.
10.10.1 Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
10.10.2 Pfizer Inc. Bipolar Disorder Medications Models, Specifications, and Application
10.10.3 Pfizer Inc. Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Pfizer Inc. Company Profile and Main Business
10.10.5 Pfizer Inc. Recent Developments
10.11 Novartis AG
10.11.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.11.2 Novartis AG Bipolar Disorder Medications Models, Specifications, and Application
10.11.3 Novartis AG Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novartis AG Company Profile and Main Business
10.11.5 Novartis AG Recent Developments
10.12 Otsuka Holdings Co. Ltd
10.12.1 Otsuka Holdings Co. Ltd Company Information, Head Office, Market Area, and Industry Position
10.12.2 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Models, Specifications, and Application
10.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Otsuka Holdings Co. Ltd Company Profile and Main Business
10.12.5 Otsuka Holdings Co. Ltd Recent Developments
10.13 Validus Pharmaceuticals LLC.
10.13.1 Validus Pharmaceuticals LLC. Company Information, Head Office, Market Area, and Industry Position
10.13.2 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Models, Specifications, and Application
10.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Validus Pharmaceuticals LLC. Company Profile and Main Business
10.13.5 Validus Pharmaceuticals LLC. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Bipolar Disorder Medications Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Bipolar Disorder Medications Market Restraints
Table 3. Bipolar Disorder Medications Market Trends
Table 4. Bipolar Disorder Medications Industry Policy
Table 5. Global Bipolar Disorder Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Bipolar Disorder Medications Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Bipolar Disorder Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Bipolar Disorder Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Bipolar Disorder Medications Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Bipolar Disorder Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Bipolar Disorder Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Bipolar Disorder Medications Manufacturers Product Type
Table 13. Head Office and Bipolar Disorder Medications Production Site of Key Manufacturer
Table 14. Bipolar Disorder Medications Capacity of Major Manufacturers and Future Plan
Table 15. China Bipolar Disorder Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Bipolar Disorder Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Bipolar Disorder Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Bipolar Disorder Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Bipolar Disorder Medications Production by Region, 2018-2023, (K Units)
Table 20. Global Bipolar Disorder Medications Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Bipolar Disorder Medications Upstream (Raw Materials)
Table 22. Global Bipolar Disorder Medications Typical Customers
Table 23. Bipolar Disorder Medications Typical Distributors
Table 24. By Type, Global Bipolar Disorder Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Bipolar Disorder Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Bipolar Disorder Medications Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Bipolar Disorder Medications Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Bipolar Disorder Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Bipolar Disorder Medications Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Bipolar Disorder Medications Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Bipolar Disorder Medications Sales Quantity Market Share, 2018-2029
Table 34. AbbVie Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. AbbVie Inc. Bipolar Disorder Medications Models, Specifications, and Application
Table 36. AbbVie Inc. Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. AbbVie Inc. Company Profile and Main Business
Table 38. AbbVie Inc. Recent Developments
Table 39. Glaxo SmithKline (GSK) Company Information, Head Office, Market Area, and Industry Position
Table 40. Glaxo SmithKline (GSK) Bipolar Disorder Medications Models, Specifications, and Application
Table 41. Glaxo SmithKline (GSK) Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Glaxo SmithKline (GSK) Company Profile and Main Business
Table 43. Glaxo SmithKline (GSK) Recent Developments
Table 44. Eli Lily and Company Company Information, Head Office, Market Area, and Industry Position
Table 45. Eli Lily and Company Bipolar Disorder Medications Models, Specifications, and Application
Table 46. Eli Lily and Company Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Eli Lily and Company Company Profile and Main Business
Table 48. Eli Lily and Company Recent Developments
Table 49. Janssen Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 50. Janssen Pharmaceuticals Bipolar Disorder Medications Models, Specifications, and Application
Table 51. Janssen Pharmaceuticals Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Janssen Pharmaceuticals Company Profile and Main Business
Table 53. Janssen Pharmaceuticals Recent Developments
Table 54. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 55. Johnson & Johnson Bipolar Disorder Medications Models, Specifications, and Application
Table 56. Johnson & Johnson Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Johnson & Johnson Company Profile and Main Business
Table 58. Johnson & Johnson Recent Developments
Table 59. Astellas Pharma Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Astellas Pharma Inc Bipolar Disorder Medications Models, Specifications, and Application
Table 61. Astellas Pharma Inc Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Astellas Pharma Inc Company Profile and Main Business
Table 63. Astellas Pharma Inc Recent Developments
Table 64. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 65. Bristol Myers Squibb Bipolar Disorder Medications Models, Specifications, and Application
Table 66. Bristol Myers Squibb Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bristol Myers Squibb Company Profile and Main Business
Table 68. Bristol Myers Squibb Recent Developments
Table 69. Gedeon Richter PLC. Company Information, Head Office, Market Area, and Industry Position
Table 70. Gedeon Richter PLC. Bipolar Disorder Medications Models, Specifications, and Application
Table 71. Gedeon Richter PLC. Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Gedeon Richter PLC. Company Profile and Main Business
Table 73. Gedeon Richter PLC. Recent Developments
Table 74. H. Lundbeck A/S Company Information, Head Office, Market Area, and Industry Position
Table 75. H. Lundbeck A/S Bipolar Disorder Medications Models, Specifications, and Application
Table 76. H. Lundbeck A/S Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. H. Lundbeck A/S Company Profile and Main Business
Table 78. H. Lundbeck A/S Recent Developments
Table 79. Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
Table 80. Pfizer Inc. Bipolar Disorder Medications Models, Specifications, and Application
Table 81. Pfizer Inc. Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Pfizer Inc. Company Profile and Main Business
Table 83. Pfizer Inc. Recent Developments
Table 84. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 85. Novartis AG Bipolar Disorder Medications Models, Specifications, and Application
Table 86. Novartis AG Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Novartis AG Company Profile and Main Business
Table 88. Novartis AG Recent Developments
Table 89. Otsuka Holdings Co. Ltd Company Information, Head Office, Market Area, and Industry Position
Table 90. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Models, Specifications, and Application
Table 91. Otsuka Holdings Co. Ltd Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Otsuka Holdings Co. Ltd Company Profile and Main Business
Table 93. Otsuka Holdings Co. Ltd Recent Developments
Table 94. Validus Pharmaceuticals LLC. Company Information, Head Office, Market Area, and Industry Position
Table 95. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Models, Specifications, and Application
Table 96. Validus Pharmaceuticals LLC. Bipolar Disorder Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Validus Pharmaceuticals LLC. Company Profile and Main Business
Table 98. Validus Pharmaceuticals LLC. Recent Developments
List of Figures
Figure 1. Bipolar Disorder Medications Picture
Figure 2. Global Bipolar Disorder Medications Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Bipolar Disorder Medications Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Bipolar Disorder Medications Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Bipolar Disorder Medications Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Bipolar Disorder Medications Sales Quantity (K Units) & (2018-2029)
Figure 7. China Bipolar Disorder Medications Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Bipolar Disorder Medications Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Bipolar Disorder Medications Market Share of Global, 2018-2029
Figure 10. Global Bipolar Disorder Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Bipolar Disorder Medications Key Participants, Market Share, 2022
Figure 12. Global Bipolar Disorder Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Bipolar Disorder Medications Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Bipolar Disorder Medications Production Market Share & Forecast by Region, 2018-2029
Figure 15. Bipolar Disorder Medications Industry Chain
Figure 16. Bipolar Disorder Medications Procurement Model
Figure 17. Bipolar Disorder Medications Sales Model
Figure 18. Bipolar Disorder Medications Sales Channels, Direct Sales, and Distribution
Figure 19. Mood Stabilizers
Figure 20. Anticonvulsants
Figure 21. Antipsychotic Drugs
Figure 22. Antidepressant Drugs
Figure 23. Anti-Anxiety Drugs
Figure 24. By Type, Global Bipolar Disorder Medications Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Bipolar Disorder Medications Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Bipolar Disorder Medications Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Bipolar Disorder Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Hospital
Figure 30. Clinic
Figure 31. By Application, Global Bipolar Disorder Medications Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Bipolar Disorder Medications Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Bipolar Disorder Medications Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Bipolar Disorder Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Bipolar Disorder Medications Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Bipolar Disorder Medications Sales Quantity Market Share, 2018-2029
Figure 38. North America Bipolar Disorder Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Bipolar Disorder Medications Consumption Value Market Share, 2022
Figure 40. Europe Bipolar Disorder Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Bipolar Disorder Medications Consumption Value Market Share, 2022
Figure 42. Asia Pacific Bipolar Disorder Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Bipolar Disorder Medications Consumption Value Market Share, 2022
Figure 44. South America Bipolar Disorder Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Bipolar Disorder Medications Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Bipolar Disorder Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Bipolar Disorder Medications Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Bipolar Disorder Medications Sales Quantity Market Share, 2022 VS 2029_x0
Research Methodology:
Bipolar Disorder Medications Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|